Durcan L, Petri M. Why targeted therapies are necessary for systemic lupus erythematosus. Lupus. 2016;25(10):1070–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kurien BT, Scofield RH. Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev. 2008;7(7):567–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gurevitz SL, et al. Systemic lupus erythematosus: a review of the disease and treatment options. Consult Pharm. 2013;28(2):110–21.
Article
PubMed
Google Scholar
Tsokos GC, et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716–30.
Article
CAS
PubMed
Google Scholar
Al-Shobaili HA, Rasheed Z. Physicochemical and immunological studies on mitochondrial DNA modified by peroxynitrite: implications of neo-epitopes of mitochondrial DNA in the etiopathogenesis of systemic lupus erythematosus. Lupus. 2013;22(10):1024–37.
Article
CAS
PubMed
Google Scholar
Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev. 2008;7(7):544–9.
Article
CAS
PubMed
Google Scholar
Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329(27):2002–12.
Article
CAS
PubMed
Google Scholar
Abramson SB, et al. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol. 2001;15(5):831–45.
Article
CAS
PubMed
Google Scholar
Clancy RM, Abramson SB. Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med. 1995;210(2):93–101.
Article
CAS
PubMed
Google Scholar
Gonzalez-Gay MA, et al. Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in Northwest Spain. Rheumatology (Oxford). 2004;43(9):1182–5.
Article
CAS
Google Scholar
Souza JM, et al. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys. 1999;371(2):169–78.
Article
CAS
PubMed
Google Scholar
Gilkeson G, et al. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol. 1999;26(2):318–24.
CAS
PubMed
Google Scholar
Morgan PE, Sturgess AD, Davies MJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res. 2009;43(2):117–27.
Article
CAS
PubMed
Google Scholar
Shah D, et al. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol Lett. 2010;129(1):7–12.
Article
CAS
PubMed
Google Scholar
Mazzon E, et al. Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase. Shock. 2002;18(5):434–9.
Article
PubMed
Google Scholar
Negre-Salvayre A, et al. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol. 2008;153(1):6–20.
Article
CAS
PubMed
Google Scholar
Ahmad R, Ahsan H. Role of peroxynitrite-modified biomolecules in the etiopathogenesis of systemic lupus erythematosus. Clin Exp Med. 2014;14(1):1–11.
Article
CAS
PubMed
Google Scholar
Frostegard J, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 2005;52(1):192–200.
Article
CAS
PubMed
Google Scholar
Habib S, Moinuddin, Ali R. Peroxynitrite-modified DNA: a better antigen for systemic lupus erythematosus anti-DNA autoantibodies. Biotechnol Appl Biochem. 2006;43(Pt 2):65–70.
CAS
PubMed
Google Scholar
Khan F, Siddiqui AA, Ali R. Measurement and significance of 3-nitrotyrosine in systemic lupus erythematosus. Scand J Immunol. 2006;64(5):507–14.
Article
CAS
PubMed
Google Scholar
Oates JC, et al. Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. Proc Assoc Am Physicians. 1999;111(6):611–21.
Article
CAS
PubMed
Google Scholar
Kuhn A, et al. Aberrant timing in epidermal expression of inducible nitric oxide synthase after UV irradiation in cutaneous lupus erythematosus. J Invest Dermatol. 1998;111(1):149–53.
Article
CAS
PubMed
Google Scholar
Weinberg JB, Granger DL, Pisetsky DS, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephri- tis and arthritis by orally administered N G -monomethyl- L -arginine. J Exp Med. 1994;179:651–60.
Article
CAS
PubMed
Google Scholar
Karpuzoglu E, Ahmed SA. Estrogen regulation of nitric oxide and inducible nitric oxide synthase (iNOS) in immune cells: implications for immunity, autoimmune diseases, and apoptosis. Nitric Oxide. 2006;15(3):177–86.
Article
CAS
PubMed
Google Scholar
Mishra N, et al. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest. 2003;111(4):539–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yang CW, et al. Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice. Clin Exp Immunol. 1998;113(2):258–64.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang Z, et al. Human umbilical cord mesenchymal stem cells inhibit T follicular helper cell expansion through the activation of iNOS in lupus-prone B6.MRL-Fas(lpr) mice. Cell Transplant. 2017;26(6):1031–42.
Article
PubMed
PubMed Central
Google Scholar
Ueno H, Banchereau J, Vinuesa CG. Pathophysiology of T follicular helper cells in humans and mice. Nat Immunol. 2015;16(2):142–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014;41(4):529–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005;5(8):641–54.
Article
CAS
PubMed
Google Scholar
Al Gadban MM, et al. Lack of nitric oxide synthases increases lipoprotein immune complex deposition in the aorta and elevates plasma sphingolipid levels in lupus. Cell Immunol. 2012;276(1–2):42–51.
Article
PubMed
PubMed Central
CAS
Google Scholar
Belmont HM, et al. Increased nitric oxide production accompanied by the up-regulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40(10):1810–6.
Article
CAS
PubMed
Google Scholar
Juanqin G, et al. iNOS expression at mRNA level in peripheral blood mononucler cell in SLE. J Clin Dermatol. 2002;31(1):17-19.
Xu LT, Wang MM. The detective of NO and its production in SLE. Jingsu Med J. 2003;29(12):923–4.
CAS
Google Scholar
Zheng L, Sinniah R, Hsu SI. Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum Pathol. 2006;37(6):637–47.
Article
CAS
PubMed
Google Scholar
Bollain-y-Goytia JJ, et al. Widespread expression of inducible NOS and citrulline in lupus nephritis tissues. Inflamm Res. 2009;58(2):61–6.
Article
CAS
PubMed
Google Scholar
Wang JS, et al. Expression of inducible nitric oxide synthase and apoptosis in human lupus nephritis. Nephron. 1997;77(4):404–11.
Article
CAS
PubMed
Google Scholar
Ji J, et al. Myeloid-derived suppressor cells contribute to systemic lupus erythaematosus by regulating differentiation of Th17 cells and Tregs. Clin Sci (Lond). 2016;130(16):1453–67.
Article
CAS
Google Scholar
Vlachou K, et al. Elimination of granulocytic myeloid-derived suppressor cells in lupus-prone mice linked to reactive oxygen species-dependent extracellular trap formation. Arthritis Rheumatol. 2016;68(2):449–61.
Article
CAS
PubMed
Google Scholar
Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
O'Brien NC, et al. Nitric oxide plays a critical role in the recovery of Lewis rats from experimental autoimmune encephalomyelitis and the maintenance of resistance to reinduction. J Immunol. 1999;163(12):6841–7.
CAS
PubMed
Google Scholar
Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med. 1998;4(9):557–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang G, et al. Lipid peroxidation-derived aldehyde-protein adducts contribute to trichloroethene-mediated autoimmunity via activation of CD4+ T cells. Free Radic Biol Med. 2008;44(7):1475–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang G, et al. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arthritis Rheum. 2010;62(7):2064–72.
CAS
PubMed
PubMed Central
Google Scholar
Wang G, et al. Protein adducts of malondialdehyde and 4-hydroxynonenal contribute to trichloroethene-mediated autoimmunity via activating Th17 cells: dose- and time-response studies in female MRL+/+ mice. Toxicology. 2012;292(2–3):113–22.
Article
CAS
PubMed
Google Scholar
Levesque MC, Weinberg JB. The dichotomous role of nitric oxide in the pathogenesis of accelerated atherosclerosis associated with systemic lupus erythematosus. Curr Mol Med. 2004;4(7):777–86.
Article
CAS
PubMed
Google Scholar
Oates JC, Gilkeson GS. Nitric oxide induces apoptosis in spleen lymphocytes from MRL/lpr mice. J Investig Med. 2004;52(1):62–71.
CAS
PubMed
Google Scholar
Wang D, et al. A CD8 T cell/indoleamine 2,3-dioxygenase axis is required for mesenchymal stem cell suppression of human systemic lupus erythematosus. Arthritis Rheumatol. 2014;66(8):2234–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cianciulli A, et al. PI3k/Akt signalling pathway plays a crucial role in the anti-inflammatory effects of curcumin in LPS-activated microglia. Int Immunopharmacol. 2016;36:282–90.
Article
CAS
PubMed
Google Scholar
Park MJ, et al. Myeloid-derived suppressor cells induce the expansion of regulatory B cells and ameliorate autoimmunity in the Sanroque mouse model of systemic lupus Erythematosus. Arthritis Rheumatol. 2016;68(11):2717–27.
Article
CAS
PubMed
Google Scholar
Keng T, et al. Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice. Mol Med. 2000;6(9):779–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
Reilly CM, et al. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Kidney Int. 2002;61(3):839–46.
Article
CAS
PubMed
Google Scholar
Takeda Y, et al. Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol. 2004;138(2):237–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lui SL, et al. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lupus. 2002;11(7):411–8.
Article
CAS
PubMed
Google Scholar
Yu CC, et al. Mycophenolate mofetil reduces renal cortical inducible nitric oxide synthase mRNA expression and diminishes glomerulosclerosis in MRL/lpr mice. J Lab Clin Med. 2001;138(1):69–77.
Article
CAS
PubMed
Google Scholar
Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 2001;33(11):1897–918.
Article
CAS
PubMed
Google Scholar
Dusting GJ, et al. Nitric oxide in atherosclerosis: vascular protector or villain? Clin Exp Pharmacol Physiol Suppl. 1998;25:S34–41.
Article
CAS
PubMed
Google Scholar
Wells GS, S.B., O’Connell D, et al. The Newcatle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hospital Research Institute, 2013. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 17 Jan 2019.
Mak A, Liu Y, Ho RC. Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression. J Rheumatol. 2011;38(7):1296–303.
Article
PubMed
Google Scholar
Higgins JP, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
Article
PubMed
PubMed Central
Google Scholar
Higgins JPT, G. S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org/. Accessed July 2012.